Premenstrual Dysphoric Disorder (PMDD) affects approximately 1 in 20 women of reproductive age and is frequently overlooked in clinical settings. Symptoms include severe mood swings, anxiety, depression, and suicidal thoughts, leading to disruptions in daily life. Effective treatment options involve a combination of lifestyle changes, therapy, and medication. There is a pressing need to enhance awareness and increase funding for research on PMDD to improve diagnosis and care for those living with this condition. Despite advancements in women's health discussions, PMDD continues to remain underdiagnosed.
Premenstrual Dysphoric Disorder (PMDD) is a hormone-related mood disorder that occurs in the luteal phase of the menstrual cycle, affecting up to 1 in 20 women.
Symptoms of PMDD can include severe mood swings, depression, anxiety, and even suicidal thoughts, which significantly disrupt daily functioning.
Effective treatment for PMDD often includes lifestyle changes, therapy, and medication, emphasizing the need for tailored support and understanding.
Increasing awareness and funding for research on PMDD is crucial to improving diagnosis and care for those affected by this debilitating condition.
Collection
[
|
...
]